Ischaemic Preconditioning of Myocardium

References

• Murry C E, Jennings R B, Reimer K A. Preconditioning with ischemia: a delay of lethal injury in ischemic myocardium. Circulation 1986; 74: 1124–36
   PubMed Web of Science ®Google Scholar
• Reimer K A, Murry C E, Yamasawa I, Hill M L, Jennings R B. Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol 1986; 251: H1306–15
   PubMed Web of Science ®Google Scholar
• Miura T, Limura O. Infarct limitation by preconditioning: its phenomenological features and the key role of adenosine. Cardiovasc Res 1993; 27: 36–42
   PubMedGoogle Scholar
• Van Winkle D M, Thornton J, Downey J M. Cardio-protection from ischemic preconditioning is lost following prolonged reperfusion in the rabbit. Coronary Artery Dis 1991; 2: 613–9
   Web of Science ®Google Scholar
• Burckhartt B, Yang X M, Tsuchida A, Mullane K M, Downey J M, Cohen M V. Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits. Cardiovasc Res 1995; 29: 653–7
   PubMed Web of Science ®Google Scholar
• Yellon D M, Baxter G F. A second window of protection or delayed preconditioning phenomenon: future horizons for myocardial protection?. J Mol Cell Cardiol 1995; 27: 1023–34
   PubMed Web of Science ®Google Scholar
• Parratt J R, Szekeres L. Delayed protection of the heart against ischaemia. Trends Pharmacol Sci 1995; 16: 351–5
   PubMedGoogle Scholar
• Richard V, Kaeffer N, Thuillez C. Delayed protection of the ischemic heart - from pathophysiology to therapeutic applications. Fundam Clin Pharmacol 1996; 10: 409–15
   PubMedGoogle Scholar
• Liu G S, Thornton J, Van Winkle D M, Stanley A WH, Olsson R A, Downey J M. Protection against infarction afforded by preconditioning is mediated by adenosine A1 receptors in rabbit heart. Circulation 1991; 84: 350–6
   PubMed Web of Science ®Google Scholar
• Thornton J D, Liu G S, Olsson R A, Downey J M. Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 1992; 85: 659–65
   PubMed Web of Science ®Google Scholar
• Tsuchida A, Liu G S, Wilborn W H, Downey J M. Pre treatment with the adenosine A1 agonist, 2-chloro-N6-cyclopentyladenosine (CCPA), causes a sustained limitation of infarct size in rabbits. Cardiovasc Res 1993; 27: 652–6
   PubMed Web of Science ®Google Scholar
• Schulz R, Rose J, Post H, Heusch G. Involvement of endogenous adenosine in ischaemic preconditioning in swine. PflugersArch 1995; 430: 273–82
   PubMed Web of Science ®Google Scholar
• Auchampach J A, Gross G J. Adenosine A1 receptors, KATP channels and ischemic preconditioning in dogs. Am J Physiol 1993; 264: H1327–36
   Google Scholar
• Goto M, Liu Y, Yang X -M, Ardell J L, Cohen M V, Downey J M. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995; 77: 611–21
   PubMed Web of Science ®Google Scholar
• Speechly-Dick M E, Mocanu M M, Yellon D, Protein M., Kinase C. Its role in ischemic preconditioning in the rat. Circ Res 1994; 75: 586–90
   PubMed Web of Science ®Google Scholar
• Ytrehus K, Liu Y, Downey J M. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994; 266: H1145–52
   PubMedGoogle Scholar
• Liu Y, Cohen M V, Downey J M. Chelerythrine, a highly selective protein kinase C inhibitor, blocks the anti-infarct effect of ischemic preconditioning in rabbit hearts. Cardio-vasc Drugs Ther 1994; 8: 881–2
   PubMedGoogle Scholar
• Brooks G, Hearse D J. Role of protein kinase C in ischemic preconditioning: player or spectator?. Circ Res 1996; 79: 627–30
   PubMedGoogle Scholar
• Baines C P, Cohen M V, Downey J M. Protein tyrosine kinase inhibitor, genistein, blocks preconditioning in isolated rabbit hearts. Circulation 1996; 94(Suppl)661
   Google Scholar
• Maulik N, Watanabe M, Zu Y -L, et al. Ischemic preconditioning tiggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 1996; 396: 233–7
   PubMed Web of Science ®Google Scholar
• Hearse D J. Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection?. Cardiovasc Res 1995; 30: 1–17
   PubMed Web of Science ®Google Scholar
• Toombs C F, Moore T L, Shebuski R J. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc Res 1993; 27: 617–22
   PubMed Web of Science ®Google Scholar
• Gross G J, Auchampach J A. Blockade of the ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992; 70: 223–33
   PubMed Web of Science ®Google Scholar
• Schultz J J, Qian Y Z, Gross G J, Kukreja R C. The ischemia-selective KATP channel antagonist, 5-hydroxy-decanoate, blocks ischemic preconditioning in the rat heart. J Mol Cell Cardiol 1997; 29: 1055–60
   PubMedGoogle Scholar
• Van-Winkle D M, Chien G L, Wolff R A, Soifer B E, Kuzume K, Davis R F. Cardioprotection provided by adenosine receptor activation is abolished by blockade of the KATP channel. Am J Physiol 1994; 266: H829–39
   Google Scholar
• Speechly Dick M E, Graver G J, Yellon D M. Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K+ channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 1995; 77: 1030–5
   PubMedGoogle Scholar
• Liu Y, Gao W D, O'Rourke B, Marban E. Synergistic modulation of ATP-sensitive K+ currents by protein kinase C and adenosine. Implications for ischemic preconditioning. Circ Res 1996; 78: 443–54
   PubMedGoogle Scholar
• Hu K, Duan D, Li G R, Nattel S. Protein kinase C activates ATP-sensitive K+ current in human and rabbit ventricular myocytes. Circ Res 1996; 78: 492–8
   PubMed Web of Science ®Google Scholar
• Kim S O, Salh B, Polech S L, Wong G, Katz S. Activation of MAPKAP kinase-2 by adenosine in rat heart. J NIH Res 1997; 9: 54
   Google Scholar
• Marber M S, Latchman D S, Walker J M, Yellon D M. Cardiac stress protein elevation 24 hours following brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993; 88: 1264–72
   PubMed Web of Science ®Google Scholar
• Kuzuya T, Hoshida S, Yamashita N, et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993; 72: 1293–9
   PubMed Web of Science ®Google Scholar
• Baxter G F, Goma F M, Yellon D M. Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium. Basic Res Cardiol 1997; 92: 159–67
   PubMed Web of Science ®Google Scholar
• Baxter G F, Marber M S, Patel V C, Yellon D M. Adenosine receptor involvement in a delayed phase of myocardial protection 24 h after ischemic preconditioning. Circulation 1994; 90: 2993–3000
   PubMedGoogle Scholar
• Baxter G F, Yellon D M. Time course of delayed myocardial protection after transient adenosine A1 receptor activation in the rabbit. J Cardiovasc Pharmacol, in press
   Google Scholar
• Zhou X, Zhai X, Ashraf M. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation 1996; 93: 1177–84
   PubMed Web of Science ®Google Scholar
• Baxter G F, Goma F M, Yellon D M. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br J Pharmacol 1995; 115: 222–24
   PubMedGoogle Scholar
• Baxter G F, Mocanu M M, Yellon D M. Attenuation of myocardial ischaemic injury 24 hours after diacylglycerol treatment in vivo. J Mol Cell Cardiol 1997; 29: 1967–75
   PubMedGoogle Scholar
• Imagawa J, Baxter G F, Yellon D M. Genistein, a tyrosine kinase inhibitor, blocks the ‘second window of protection’ 48 hours after ischemic preconditioning in the rabbit. J Mol Cell Cardiol 1997; 29: 1885–93
   PubMedGoogle Scholar
• Knight R J, Buxton D B. Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reper-fusion in the perfused rat heart. Biochem Biophys Res Commun 1996; 218: 83–8
   PubMed Web of Science ®Google Scholar
• Bogoyevitch M A, Gillespie-Brown J, Ketterman A J, et al. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res 1996; 79: 162–73
   PubMed Web of Science ®Google Scholar
• Hoshida S, Kuzuya T, Fuji H, et al. Sublethal ischemia alters myocardial antioxidant activity in canine heart. Am J Physiol 1993; 264: H33–9
   Google Scholar
• Yamashita N, Nishida M, Hoshida S, et al. Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. J Clin Invest 1994; 94: 2193–9
   PubMedGoogle Scholar
• Yellon D M, Marber M S. Hsp70 in myocardial ischaemia. Experientia 1994; 50: 1075–84
   PubMedGoogle Scholar
• Dillmann W H, Mehta H B, Barrieux A, Guth B D, Neeley W E, Ross J. Ischemia of the dog heart induces the appearance of a cardiac mRNA coding for a protein with migration characteristics similar to heat shock/stress protein 71. Circ Res 1986; 59: 110–4
   PubMedGoogle Scholar
• Knowlton A A, Brecher P, Apstein C S. Rapid expression of heat shock protein in the rabbit after brief cardiac ischemia. J Clin Invest 1991; 87: 139–47
   PubMed Web of Science ®Google Scholar
• Yao Z, Auchampach J A, Pieper G M, Gross G J. Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog. Cardiovasc Res 1993; 27: 832–8
   PubMedGoogle Scholar
• Zhao L, Weber P A, Comerford M L, Smith J R, Kehl J, Elliott G T. Role of inducible nitric oxide synthase (iNOS) in pharmacological ‘preconditioning’ with monophosphoryl lipid A. Circulation 1996; 94(Suppl)422
   Google Scholar
• Vegh A, Papp J G, Parratt J R. Prevention by dexametha-sone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br J Pharmacol 1994; 113: 1081–2
   PubMedGoogle Scholar
• Cameron J S, Kibler K KA, Berry H, Barron D N, Sodder V H. Nitric oxide activates ATP-sensitive potassium channels in hypertrophied ventricular myocytes. FASEB J 1996; 10: A65
   Google Scholar
• Mei D A, Elliott G T, Gross G J. ATP-sensitive K+ channels mediate the cardioprotective effect of monophosphoryl lipid A. Circulation 1995; 92(Suppl)388
   PubMedGoogle Scholar
• Walker D M, Walker J M, Pugsley W B, Pattison C W, Yellon D M. Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol 1995; 27: 1349–57
   PubMed Web of Science ®Google Scholar
• Morris S D, Yellon D M. Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradykinin B2 receptor activation in human heart. J Am Coll Cardiol 1997; 29: 1599–606
   PubMed Web of Science ®Google Scholar
• Deutsch E, Berger M, Kussmaul W G, Hirshfeld J W, Herrmann H C, Laskey W K. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical, hemodynamic and metabolic features. Circulation 1990; 82: 2044–51
   PubMed Web of Science ®Google Scholar
• Cribier A, Korstaz L, Koning R, et al. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. J Am Coll Cardiol 1992; 20: 578–86
   PubMed Web of Science ®Google Scholar
• Tomai F, Crea F, Gaspardone A, et al. Effects of A1 adenosine receptor blockade by bamiphylline on ischemic preconditioning during coronary angioplasty. Eur Heart J 1996; 17: 846–53
   PubMed Web of Science ®Google Scholar
• Tomai F, Crea F, Gaspardone A, et al. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation 1994; 90: 700–5
   PubMed Web of Science ®Google Scholar
• Yellon D M, Alhulaifi A M, Pugsley W B. Preconditioning the human myocardium. Lancet 1993; 342: 276–7
   PubMed Web of Science ®Google Scholar
• Jenkins D P, Pugsley W B, Alkhulaifi A M, Kemp M, Hooper J, Yellon D M. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 1997; 77: 314–8
   PubMed Web of Science ®Google Scholar
• Marber M S, Yellon D M, Joy M. Is warm-up angina preconditioning?. Br Heart J 1994; 72: 213–5
   PubMedGoogle Scholar
• MacAlpin R N, Kattus A A. Adaptation to exercise in angina pectoris. Circulation 1966; 33: 183–201
   PubMed Web of Science ®Google Scholar
• Okazaki Y, Kodama K, Sato H, et al. Attenuation of increased regional myocardial oxygen consumption during exercise as a major cause of warm-up phenomenon. J Am Coll Cardiol 1993; 21: 1597–604
   PubMed Web of Science ®Google Scholar
• Williams D O, Bass T A, Gewirtz H, Most A S. Adaptation to the stress of tachycardia in patients with coronary artery disease: insight into the mechanism of the warm-up phenomenon. Circulation 1985; 71: 687–92
   PubMed Web of Science ®Google Scholar
• Yellon D M, Baxter G F, Marber M S. Angina re-assessed: pain or protector?. Lancet 1996; 347: 1059–62
   Google Scholar
• Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infarct size: a role for ischemic preconditioning. Circulation 1995; 91: 291–7
   PubMed Web of Science ®Google Scholar
• Nakagawa Y, Ito H, Kitakaze M, et al. Effect of angina pectoris on myocardial protection in patients with reper-fused anterior wall myocardial infarction: retrospective clinical evidence of ‘preconditioning’. J Am Coll Cardiol 1995; 25: 1076–83
   PubMed Web of Science ®Google Scholar
• Gaspardone A, Crea F, Tomai F, et al. Muscular and cardiac adenosine-induced pain is mediated by A1 receptors. J Am Coll Cardiol 1995; 25: 251–7
   PubMed Web of Science ®Google Scholar